Latest profit margin for Botanix Pharmaceuticals Limited: -387.63% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Botanix Pharmaceuticals Limited (BOT.AX) currently reports a profit margin of -387.63% as of June 2026. That compares with -771.45% in the prior-year period — up 49.8% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Botanix Pharmaceuticals Limited's profit margin history and peer comparisons.
Botanix Pharmaceuticals Limited's profit margin increased from -771.45% to -387.63% — a 49.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Botanix Pharmaceuticals Limited's profit margin of -387.63% is lower than the Healthcare sector average of 17.63%. That is roughly 2298.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Botanix Pharmaceuticals Limited's current -387.63% should be judged against Healthcare norms (sector average: 17.63%) and against BOT.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -387.63%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Botanix Pharmaceuticals Limited, and consider following BOT.AX for alerts when major investors trade the stock.